Literature DB >> 25110405

Intestinal antigen-presenting cells in mucosal immune homeostasis: crosstalk between dendritic cells, macrophages and B-cells.

Elizabeth R Mann1, Xuhang Li1.   

Abstract

The intestinal immune system maintains a delicate balance between immunogenicity against invading pathogens and tolerance of the commensal microbiota. Inflammatory bowel disease (IBD) involves a breakdown in tolerance towards the microbiota. Dendritic cells (DC), macrophages (MΦ) and B-cells are known as professional antigen-presenting cells (APC) due to their specialization in presenting processed antigen to T-cells, and in turn shaping types of T-cell responses generated. Intestinal DC are migratory cells, unique in their ability to generate primary T-cell responses in mesenteric lymph nodes or Peyer's patches, whilst MΦ and B-cells contribute to polarization and differentiation of secondary T-cell responses in the gut lamina propria. The antigen-sampling function of gut DC and MΦ enables them to sample bacterial antigens from the gut lumen to determine types of T-cell responses generated. The primary function of intestinal B-cells involves their secretion of large amounts of immunoglobulin A, which in turn contributes to epithelial barrier function and limits immune responses towards to microbiota. Here, we review the role of all three types of APC in intestinal immunity, both in the steady state and in inflammation, and how these cells interact with one another, as well as with the intestinal microenvironment, to shape mucosal immune responses. We describe mechanisms of maintaining intestinal immune tolerance in the steady state but also inappropriate responses of APC to components of the gut microbiota that contribute to pathology in IBD.

Entities:  

Keywords:  Antigen presenting cells; B cells; Dendritic cells; Inflammatory bowel disease; Macrophages

Mesh:

Substances:

Year:  2014        PMID: 25110405      PMCID: PMC4123356          DOI: 10.3748/wjg.v20.i29.9653

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  153 in total

Review 1.  Secretory IgA: arresting microbial pathogens at epithelial borders.

Authors:  Nicholas J Mantis; Stephen J Forbes
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

Review 2.  Toll-like receptor and RIG-I-like receptor signaling.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

3.  Immunoglobulins drive terminal maturation of splenic dendritic cells.

Authors:  Natalia Zietara; Marcin Łyszkiewicz; Jacek Puchałka; Gang Pei; Maximiliano Gabriel Gutierrez; Stefan Lienenklaus; Elias Hobeika; Michael Reth; Vitor A P Martins dos Santos; Andreas Krueger; Siegfried Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-23       Impact factor: 11.205

4.  An independent subset of TLR expressing CCR2-dependent macrophages promotes colonic inflammation.

Authors:  Andrew M Platt; Calum C Bain; Yvonne Bordon; David P Sester; Allan McI Mowat
Journal:  J Immunol       Date:  2010-05-07       Impact factor: 5.422

5.  The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model.

Authors:  Tamar Tadmor; Yu Zhang; Hyun-Mi Cho; Eckhard R Podack; Joseph D Rosenblatt
Journal:  Cancer Immunol Immunother       Date:  2011-01-21       Impact factor: 6.968

6.  Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria.

Authors:  Limin Shang; Masayuki Fukata; Nanthakumar Thirunarayanan; Andrea P Martin; Paul Arnaboldi; David Maussang; Cecilia Berin; Jay C Unkeless; Lloyd Mayer; Maria T Abreu; Sergio A Lira
Journal:  Gastroenterology       Date:  2008-04-22       Impact factor: 22.682

7.  Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues.

Authors:  Daniel J Campbell; Eugene C Butcher
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

8.  Essential role for CD103 in the T cell-mediated regulation of experimental colitis.

Authors:  Oliver Annacker; Janine L Coombes; Vivianne Malmstrom; Holm H Uhlig; Tim Bourne; Bengt Johansson-Lindbom; William W Agace; Christina M Parker; Fiona Powrie
Journal:  J Exp Med       Date:  2005-10-10       Impact factor: 14.307

9.  BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.

Authors:  P Schneider; F MacKay; V Steiner; K Hofmann; J L Bodmer; N Holler; C Ambrose; P Lawton; S Bixler; H Acha-Orbea; D Valmori; P Romero; C Werner-Favre; R H Zubler; J L Browning; J Tschopp
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

10.  Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions.

Authors:  Olga Schulz; Elin Jaensson; Emma K Persson; Xiaosun Liu; Tim Worbs; William W Agace; Oliver Pabst
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

View more
  31 in total

Review 1.  Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy.

Authors:  Weiwei Jiang; Xuhang Li
Journal:  Mol Diagn Ther       Date:  2015-06       Impact factor: 4.074

Review 2.  MicroRNA in gastrointestinal cell signalling.

Authors:  Priyanka Mishra; Divya Singh; Lilly Ganju; Bhuvnesh Kumar
Journal:  Inflammopharmacology       Date:  2017-11-06       Impact factor: 4.473

3.  Intestinal dendritic cells change in number in fulminant hepatic failure.

Authors:  Xu Cao; Mei Liu; Peng Wang; Dong-Yan Liu
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

4.  Adiponectin confers protection from acute colitis and restricts a B cell immune response.

Authors:  Stephanie Obeid; Miriam Wankell; Berenice Charrez; Jade Sternberg; Roxane Kreuter; Saeed Esmaili; Mehdi Ramezani-Moghadam; Carol Devine; Scott Read; Prithi Bhathal; Andreas Lopata; Golo Ahlensteil; Liang Qiao; Jacob George; Lionel Hebbard
Journal:  J Biol Chem       Date:  2017-03-03       Impact factor: 5.157

5.  Antibiotic exposures and the development of pediatric autoimmune diseases: a register-based case-control study.

Authors:  Heli T Viljakainen; Kaija-Leena Kolho; Laura K Räisänen; Sohvi E Kääriäinen; Reijo Sund; Elina Engberg
Journal:  Pediatr Res       Date:  2022-07-19       Impact factor: 3.953

Review 6.  The Innate Immune System: A Trigger for Many Chronic Inflammatory Intestinal Diseases.

Authors:  Nobuhiko Kamada; Gerhard Rogler
Journal:  Inflamm Intest Dis       Date:  2016-04-28

7.  Cytokine, antibody and proliferative cellular responses elicited by Taenia solium calreticulin upon experimental infection in hamsters.

Authors:  Fela Mendlovic; Mayra Cruz-Rivera; Guillermina Ávila; Gilberto Vaughan; Ana Flisser
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

Review 8.  The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials.

Authors:  Maria Jose Saez-Lara; Carolina Gomez-Llorente; Julio Plaza-Diaz; Angel Gil
Journal:  Biomed Res Int       Date:  2015-02-22       Impact factor: 3.411

9.  Class A1 scavenger receptors mediated macrophages in impaired intestinal barrier of inflammatory bowel disease.

Authors:  Chenxi Xie; Yanyun Fan; Yinshi Huang; Shuangting Wu; Haimei Xu; Lupeng Liu; Yiqun Hu; Qingwen Huang; Huaxiu Shi; Lin Wang; Hongzhi Xu; Jingling Su; Jianlin Ren
Journal:  Ann Transl Med       Date:  2020-02

10.  CD16+CD163+ monocytes traffic to sites of inflammation during necrotizing enterocolitis in premature infants.

Authors:  Oluwabunmi O Olaloye; Peng Liu; Jessica M Toothaker; Blake T McCourt; Collin C McCourt; Jenny Xiao; Erica Prochaska; Spenser Shaffer; Lael Werner; Jordan Gringauz; Misty Good; Jeffrey D Goldsmith; Xiaojing An; Fujing Wang; Scott B Snapper; Dror Shouval; Kong Chen; George Tseng; Liza Konnikova
Journal:  J Exp Med       Date:  2021-07-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.